BioCentury
ARTICLE | Clinical News

Biovista preclinical data

April 13, 2009 7:00 AM UTC

In a mouse model of MS, BVA-101 significantly reduced symptoms, the magnitude of which was statistically similar to reductions induced by dexamethasone. BVA-101, which is an undisclosed drug that Biov...